Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y000206 | — |
no AE; GARDASIL 9 was administered to a 6-month-old patient; This spontaneous report was received from a Physician and refers to a 6-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-Feb-2025, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #Y000206, expiration date: 23-Sep-2026) 0.5 mL for prophylaxis. On 19-Feb-2025, the patient was vaccinated GARDASIL 9 (inappropriate age at vaccination). No adverse events reported.